You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK)參與設立廣藥基金二期
格隆匯 07-25 19:53

格隆匯7月25日丨白雲山(00874.HK)公吿,於2025年7月25日,公司與廣藥資本訂立合夥協議。據此,公司、廣藥資本分別出資人民幣149,850.00萬元、人民幣150.00萬元參與設立廣藥基金二期。公司實質控制廣藥基金二期,其財務業績將納入公司的合併財務報表。

經營範圍: 以私募基金從事股權投資、投資管理、資產管理等活動(須在中國證券投資基金業協會完成備案登記後方可從事經營活動)。

本次參與設立廣藥基金二期旨在把握行業發展機遇,加快推進公司在生物醫藥健康領域產業佈局,加大公司在醫藥健康產業孵化及投資力度。本次投資有利於公司發現和培育符合公司主業發展方向、具有一定市場競爭力的項目標的,在豐富公司產業結構的同時,為公司未來可持續發展提供項目儲備。同時有利於公司提升資本運作能力及加快對外投資步伐,將促進公司加速在生物醫藥健康產業領域的轉型升級,實現快速發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account